Breakfast Intake Affects Glucose Regulation All Day in T2D

This article originally appeared here.
Share this content:
Breakfast Intake Affects Glucose Regulation All Day in T2D
Breakfast Intake Affects Glucose Regulation All Day in T2D

MONDAY, Aug. 10, 2015 (HealthDay News) -- Breakfast consumption influences glucose regulation throughout the day in patients with diabetes, according to a small study published online July 28 in Diabetes Care.

Daniela Jakubowicz, M.D., from Tel Aviv University in Israel, and colleagues conducted a crossover study in which 22 patients with diabetes (mean age, 56.9 years; body mass index, 28.2 kg/m²; and glycated hemoglobin, 7.7 percent) were randomly assigned to two test days: one day with breakfast, lunch, and dinner (YesB) and another with lunch and dinner but no breakfast (NoB).

The researchers found that lunch area under the curves for 0 to 180 minutes (AUC0-180) for plasma glucose, free fatty acids (FFA), and glucagon were 36.8, 41.1, and 14.8 percent higher, respectively, while the AUC0-180 for insulin and intact glucagon-like peptide-1 (iGLP-1) were 17 and 19 percent lower, respectively, on the NoB day compared with YesB (P < 0.0001). Dinner AUC0-180 for glucose, FFA, and glucagon were 26.6, 29.6, and 11.5 percent higher, respectively, while AUC0-180 for insulin and iGLP-1 were 7.9 and 16.5 percent lower, respectively, on the NoB day compared with the YesB day (P < 0.0001). On the NoB day, insulin peak was delayed 30 minutes after lunch and dinner, compared with the YesB day.

"Breakfast consumption could be a successful strategy for reduction of postprandial hyperglycemia in type 2 diabetes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »